How should I use MEXTOVI(Binimetinib)?

The recommended dosage is 45 mg taken orally twice daily, with specific adjustments for hepatic impairment.

Recommended Dosage

The standard dosage of MEXTOVI is 45 mg orally twice daily, approximately 12 hours apart, always administered in combination with encorafenib. It can be taken with or without food. A missed dose should be taken unless it is within 6 hours of the next scheduled dose. For patients with moderate or severe hepatic impairment, the dose must be reduced to 30 mg twice daily. Dose interruptions, reductions, or discontinuation are required based on the type and severity of adverse reactions.

MEXTOVI(Binimetinib)
Kinase inhibitor used in combination with encorafenib for the treatment of BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma, and BRAF V600E...
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved